Join CBMTG | Print Page | Contact Us | Sign In
Board Of Directors

PRESIDENT
Andrew Daly, MD
Dr. Andrew Daly received his medical training at McGill University in Montreal. He subsequently completed post-graduate training in hematology at McGill and a fellowship in hematopoietic stem cell transplantation at the University of Toronto. He is currently the director of the Alberta Blood and Marrow Transplant Program at the University of Calgary and a clinical associate professor at the Cumming School of Medicine, University of Calgary. His research interests include expanding access to hematopoietic cell transplantation through the use of alternative donors and improving the outcome of transplantation through the use or safer preparative regimens.


PRESIDENT-ELECT
Donna Wall, MD

Dr. Donna Wall received medical training at the University of Manitoba, followed by post graduate training at Columbia Presbyterian in New York, Tufts New England Medical Center in Boston, and the Dana Farber Cancer Institute/The Children's Hospital in Boston. She has developed and run pediatric blood and marrow transplant programs at Washington University, St. Louis University in Missouri, and the Texas Transplant Institute/Methodist Children's Hospital in San Antonio, Texas. She is currently the director of the Manitoba Blood and Marrow Transplant Program in Winnipeg. She has chaired the pediatric blood and marrow transplant consortium and the children's oncology group stem cell transplant discipline. Her research interests include cord blood biology and transplantation, treatment of childhood leukemia and the regenerative potential of mesenchymal cells.


PAST PRESIDENT
Christopher Bredeson, MD, MSc, FRCPC

Dr. Christopher Bredeson is currently the head of malignant hematology and SCT in Ottawa and a senior scientist in the clinical epidemiology program of the Ottawa Hospital Research Institute. In 2011, he returned to Ottawa after a decade in the United States and a year in Manitoba. While in the United States, he worked as a scientific director at the CIBMTR and helped establish the BMT Clinical Trials Network. He has extensive experience in clinical research design and conduct in SCT, in both observational research methods and prospective clinical trials. One of his favourite roles has been serving as a faculty mentor for the ASBMT Clinical Research Training Institute for each of the past five summers.


TREASURER

Raewyn Broady, MBChB, FRACP, FRCPA, FRCPC

Dr. Raewyn Broady is interim director of the Leukemia/BMT Program of BC. She trained as a hematologist in New Zealand. She completed a fellowship in leukemia and stem cell transplant with the Leukemia/BMT Program of BC in 2001. After spending two years working as a post-doctoral fellow in Italy, she joined the medical staff at Vancouver General Hospital in 2003 and became an attending staff with the leukemia/BMT in 2006. Her laboratory and clinical research interests include management of long-term complications and opportunistic infections following high dose chemotherapy and stem cell transplantation.


SECRETARY
Jennifer Wiernikowski, MN, NP-Adult, CON(C)

Jennifer Wiernikowski is a nurse practitioner in hematology at the Juravinski Cancer Hospital and Cancer Centre in Hamilton, Ontario. Her clinical work focuses on hematological malignancies, autologous and allogeneic stem cell and bone marrow transplants. Her previous oncology nursing roles include chief of nursing practice for the Juravinski Cancer Program at Hamilton Health Sciences and advanced practice nurse for the breast disease team at HHS. Jennifer obtained her BScN at McMaster University in 1988, and her MScN from the University of Toronto in 2003 along with her acute care nurse practitioner credential. Jennifer holds a clinical cross appointment in the school of nursing at McMaster University and is an associate member of the department of oncology, Michael G. DeGroot School of Medicine at McMaster University. Her research interests have been in the area of breast cancer, cancer survivorship, advanced nursing roles in oncology, and knowledge translation.


DIRECTOR-AT-LARGE, EDUCATION 
Kylie Lepic, MD

Dr. Kylie Lepic received her MD from McMaster University in 2006. She completed her Internal Medicine and Hematology Residency training at McMaster followed by a Fellowship in Blood and Marrow Transplant at the Fred Hutchinson Cancer Research Center in Seattle, WA. Dr. Lepic is currently an Assistant Professor in the Department of Medicine at McMaster and is based at the Juravinski Hospital and Cancer Centre. She has a special interest in histocompatibility.

  


DIRECTOR-AT-LARGE, RESEARCH
Kirk Schultz, MD

Dr. Kirk Schultz is a Professor at the University of British Columbia, BC Children’s Hospital, and the Child and Family Research Institute (CFRI). Dr. Schultz is a Pediatric Hematologist/Oncologist focused on new therapies and rejection in Blood and Marrow Transplantation (BMT) and immune therapy of blood cancers. Dr. Schultz is a past recipient of the CIHR/Wyeth Clinical Research Chair in Transplantation, past chair of the CBMTG CTN, and past chair of the Pediatric BMT Consortium the largest children’s BMT clinical trials group in the world. Dr. Schultz is also a  fellow of the Canadian Academy of Health Sciences. He is currently the director of the Michael Cuccione Childhood Cancer Research Program group at the BC Children’s Hospital and CFRI and the lead on Core 2 of the CNTRP.  


This website is sponsored by an unrestricted educational grant from:

Follow CBMTG